Boston Scientific launches NeuroSphere virtual clinic for remote DBS programming worldwide
Summary
Boston Scientific launched NeuroSphere Virtual Clinic globally, enabling Parkinson's patients with Vercise Genus DBS to have their stimulation parameters remotely programmed by neurologists without in-person visits. The platform has already processed 50,000 remote programming sessions in its US pilot, reducing average programming visit frequency from 8 to 2 per year.
Why it matters
Remote DBS programming eliminates one of the most significant barriers to DBS adoption — the burden of frequent in-person clinic visits for a patient population with mobility challenges. Reducing visits from 8 to 2 per year also dramatically reduces healthcare system costs and neurologist time, improving the economics of DBS care.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial